title: The presence of donor-specific antibodies in renal transplantation.
abstract: Determining the presence of anti-HLA antibodies before transplantation is an important factor to prevent loss of function among renal transplantations. In addition, recent studies have shown that not only the pretransplantation existence of anti-HLA antibody but also posttransplantation donor-specific antibodies (DSA) and non-donor-specific antibodies are significantly associated with allograft rejection or loss of graft function. This study presented DSA among patients after renal transplantation together with graft function and survival.
authors: Organ Transplantation Center, Trakya University, Edirne, Turkey. hilmitozkir@gmail.com
authors: H
authors: H
authors: Tozkir
authors: T
authors: T
authors: Sağiroğlu
authors: T
authors: T
authors: Kiliçarslan-Ayna
authors: S
authors: S
authors: Tan
authors: E
authors: E
authors: Çopuroğlu
authors: G
authors: G
authors: Sağiroğlu
authors: G
authors: G
authors: Sari
authors: H
authors: H
authors: Gürkan
authors: A
authors: A
authors: Sezer
mesh_terms: D003888:Desensitization, Immunologic / Q000379:methods; D046148:Donor Selection; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006648:Histocompatibility; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D014019:Tissue Donors; D016896:Treatment Outcome; D014421:Turkey
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007518:Isoantibodies